The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 31, 2018
Filed:
Nov. 16, 2015
Applicants:
Icahn School of Medicine AT Mount Sinai, New York, NY (US);
Memorial Sloan-kettering Cancer Center, New York, NY (US);
Inventors:
Peter Palese, New York, NY (US);
Adolfo Garcia-Sastre, New York, NY (US);
Dmitriy Zamarin, New York, NY (US);
Yuman Fong, New York, NY (US);
Assignees:
Icahn School of Medicine at Mount Sinai, New York, NY (US);
Memorial Sloan-Kettering Cancer Center, New York, NY (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/125 (2006.01); C12N 7/00 (2006.01); C07K 14/005 (2006.01); A61K 39/00 (2006.01); A61K 35/13 (2015.01); A61K 39/17 (2006.01);
U.S. Cl.
CPC ...
C12N 7/00 (2013.01); A61K 39/0011 (2013.01); C07K 14/005 (2013.01); A61K 35/13 (2013.01); A61K 39/17 (2013.01); C12N 2760/16122 (2013.01); C12N 2760/18121 (2013.01); C12N 2760/18122 (2013.01); C12N 2760/18132 (2013.01); C12N 2760/18143 (2013.01); C12N 2760/18171 (2013.01);
Abstract
Described herein are chimeric Newcastle disease viruses engineered to express a heterologous interferon antagonist and compositions comprising such viruses. The chimeric Newcastle disease viruses and compositions are useful in the treatment of cancer.